Related Experiment Video
Updated: May 14, 2026

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
Topical vaccination with functionalized particles targeting dendritic cells.
Renato B Baleeiro1, Karl-Heinz Wiesmüller, Yoran Reiter
1Department of Dermatology, Venerology and Allergology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and Freie Universität Berlin, Berlin, Germany.
Needle-free topical vaccines using microparticles efficiently deliver antigens to skin dendritic cells (DCs), stimulating T-cell responses for improved vaccine development. This approach enhances safety, economy, and convenience in vaccination strategies.
Area of Science:
- Immunology
- Vaccinology
- Nanotechnology
Background:
- Needle-free vaccination is a key goal for safety, cost-effectiveness, and ease of administration.
- Effective vaccination requires robust induction of both prophylactic and therapeutic immune responses.
Purpose of the Study:
- To develop microparticle-based topical vaccines for noninvasive delivery to dendritic cells (DCs).
- To assess the capacity of these microparticles to stimulate cell-mediated immunity.
Main Methods:
- Microparticles were formulated for topical skin application.
- Microparticles were designed to penetrate hair follicles and target resident DCs.
- The delivery of antigens and subsequent immune stimulation were evaluated.
Main Results:
- Microparticles efficiently delivered vaccine components to DCs for antigen cross-presentation.
- Topical application resulted in the stimulation of T-cell responses.
- The microparticle system demonstrated applicability to various antigen formats (peptides, proteins, nucleic acids).
Conclusions:
- Microparticle-based topical vaccines offer a promising needle-free strategy for inducing potent immune responses.
- This technology targets DCs within hair follicles for enhanced vaccine efficacy.
- The platform is versatile and adaptable for different vaccine antigens, advancing vaccine development.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Vaccines
Tumor Immunotherapy

